Multicenter evaluation of efficacy, tolerability and safety of a new first-line antihypertensive drug, isradipine, in a Latin-American population
G Gomez, E Melgarejo, J Narvaez… - American Journal of …, 1991 - academic.oup.com
Isradipine, a new antihypertensive dihydropyridine calcium antagonist, was evaluated for its
efficacy, tolerability, and safety in 91 ambulatory patients who had mild-to-moderate …
efficacy, tolerability, and safety in 91 ambulatory patients who had mild-to-moderate …
Multicenter evaluation of efficacy, tolerability and safety of a new first-line antihypertensive drug, isradipine, in a Latin-American population
G Gómez, E Melgarejo, J Narváez… - American journal …, 1991 - pubmed.ncbi.nlm.nih.gov
Isradipine, a new antihypertensive dihydropyridine calcium antagonist, was evaluated for its
efficacy, tolerability, and safety in 91 ambulatory patients who had mild-to-moderate …
efficacy, tolerability, and safety in 91 ambulatory patients who had mild-to-moderate …
Multicenter evaluation of efficacy, tolerability and safety of a new first-line antihypertensive drug, isradipine, in a Latin-American population.
G Gómez, E Melgarejo, J Narváez… - American Journal of …, 1991 - europepmc.org
Isradipine, a new antihypertensive dihydropyridine calcium antagonist, was evaluated for its
efficacy, tolerability, and safety in 91 ambulatory patients who had mild-to-moderate …
efficacy, tolerability, and safety in 91 ambulatory patients who had mild-to-moderate …
Multicenter evaluation of efficacy, tolerability and safety of a new first-line antihypertensive drug, isradipine, in a Latin-American population
G Gómez, E Melgarejo, J Narváez… - American Journal of …, 1991 - hero.epa.gov
Isradipine, a new antihypertensive dihydropyridine calcium antagonist, was evaluated for its
efficacy, tolerability, and safety in 91 ambulatory patients who had mild-to-moderate …
efficacy, tolerability, and safety in 91 ambulatory patients who had mild-to-moderate …